Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain

23Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to =4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cagd showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.

References Powered by Scopus

An African origin for the intimate association between humans and Helicobacter pylori

762Citations
N/AReaders
Get full text

Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins

485Citations
N/AReaders
Get full text

Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design

168Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Lifestyle and dietary environmental factors in colorectal cancer susceptibility

200Citations
N/AReaders
Get full text

Helicobacter pylori and colorectal cancer - A bacterium going abroad?

51Citations
N/AReaders
Get full text

Association between Helicobacter pylori infection and the risk of colorectal cancer: A systematic review and meta-analysis

38Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Larrea-Baz, N. F. de, Michel, A., Romero, B., Pérez-Gómez, B., Moreno, V., Martín, V., … Aragonés, N. (2017). Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain. Frontiers in Microbiology, 8(MAY). https://doi.org/10.3389/fmicb.2017.00888

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

44%

Researcher 9

33%

Professor / Associate Prof. 6

22%

Readers' Discipline

Tooltip

Medicine and Dentistry 12

46%

Biochemistry, Genetics and Molecular Bi... 7

27%

Agricultural and Biological Sciences 4

15%

Nursing and Health Professions 3

12%

Save time finding and organizing research with Mendeley

Sign up for free